Formulation Development

Research at MSN includes both generic and complex pharmaceuticals. Development of New products is a critical component of MSN’s growth.

The formulation R&D comprises of over 250 scientists engaged in generic as well as innovative products for Global requirements.

The R&D has various wings viz. Formulation development, Analytical methods development, Clinical and Pharmacokinetics and Packaging development.

All the activities are monitored and overseen by a defined program management process. We ensure the highest quality of formulation development, creating dependable, methodically similar and regulatory approved formulations. Enabled by our state-of-the-art infrastructure labs and elite scientific minds, our focus is not just to have the best products, but to manufacture them through the best processes applicable as per the regulatory standards.

We have over 250 complex products, of which a significant number of products are developed for international markets – spanning 65 countries, covering all major therapeutic areas.

The design of the formulations speaks to our Theme of Research for better medicines. Customer Satisfaction and patient safety is our top priority.

Our focus is not just to have the best products, but to manufacture them through the best processes applicable.

Right from design to manufacture, patient safety and consumer satisfaction is our top priority.

What's new

CPhI Worldwide 2020
13th - 15th Oct'20

Know more 

Our ever-growing portfolio

We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.

715

DMFs

370

APIs

90

CEPs

2000

DOSSIERs

200

FDFs

100

ANDAs

pi